Placemark Investments’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$9.43M Sell
44,357
-16,041
-27% -$3.19M 0.17% 147
2014
Q3
$10.8M Sell
60,398
-9,227
-13% -$1.53M 0.2% 121
2014
Q2
$11.8M Sell
69,625
-14,299
-17% -$2.23M 0.21% 101
2014
Q1
$10.4M Sell
83,924
-16,739
-17% -$2.04M 0.2% 112
2013
Q4
$11.2M Buy
100,663
+7,819
+8% +$747K 0.18% 129
2013
Q3
$8.4M Sell
92,844
-16,450
-15% -$1.48M 0.16% 155
2013
Q2
$9.21M Buy
+109,294
New +$11.3M 0.2% 127

Other funds holding AGN

Placemark Investments's AGN Position: Q4 2014 in Review

Placemark Investments reduced its Allergan Inc (AGN) stake by 27% in Q4 2014, selling an estimated $3.19M and leaving 44,357 shares worth $9.43M. The position accounts for 0.17% of the portfolio, ranked #147.

Placemark Investments first reported a position in AGN in Q2 2013 and has held it in 7 quarters since. The position peaked at $11.8M in Q2 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Placemark Investments held 44,357 shares of Allergan Inc worth $9.43M as of Q4 2014.
  • Placemark Investments sold 16,041 Allergan Inc shares in Q4 2014, an estimated $3.19M.
  • Allergan Inc made up 0.17% of Placemark Investments's portfolio in Q4 2014, its #147 holding.
  • Placemark Investments first reported a position in Allergan Inc in Q2 2013 and has held it in 7 quarters since.
  • Placemark Investments's Allergan Inc position peaked at $11.8M in Q2 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.